MX2022007108A - Fabricacion de do3a protegido. - Google Patents

Fabricacion de do3a protegido.

Info

Publication number
MX2022007108A
MX2022007108A MX2022007108A MX2022007108A MX2022007108A MX 2022007108 A MX2022007108 A MX 2022007108A MX 2022007108 A MX2022007108 A MX 2022007108A MX 2022007108 A MX2022007108 A MX 2022007108A MX 2022007108 A MX2022007108 A MX 2022007108A
Authority
MX
Mexico
Prior art keywords
manufacturing
do3a
protected
protected do3a
tri
Prior art date
Application number
MX2022007108A
Other languages
English (en)
Inventor
Sonia Gazzetto
Aurelia Ferrigato
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Publication of MX2022007108A publication Critical patent/MX2022007108A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

La invención se refiere a un proceso para la preparación de un paso y aislamiento de una DO3A protegido tal como éster tri-ter-butílico de DO3A como una sal sólida.
MX2022007108A 2019-12-13 2020-12-09 Fabricacion de do3a protegido. MX2022007108A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19215900 2019-12-13
PCT/EP2020/085265 WO2021116165A1 (en) 2019-12-13 2020-12-09 Manufacturing of protected do3a

Publications (1)

Publication Number Publication Date
MX2022007108A true MX2022007108A (es) 2022-07-11

Family

ID=68916319

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022007108A MX2022007108A (es) 2019-12-13 2020-12-09 Fabricacion de do3a protegido.

Country Status (13)

Country Link
US (1) US20230040042A1 (es)
EP (1) EP4073045B1 (es)
JP (1) JP2023506447A (es)
KR (1) KR20220113936A (es)
CN (1) CN114845998B (es)
AU (1) AU2020399182A1 (es)
BR (1) BR112022009493A2 (es)
CA (1) CA3157618A1 (es)
ES (1) ES2980849T3 (es)
IL (1) IL293806A (es)
MX (1) MX2022007108A (es)
WO (1) WO2021116165A1 (es)
ZA (1) ZA202205300B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022317221A1 (en) * 2021-07-27 2023-11-16 Bracco Imaging Spa Manufacturing of dimeric contrast agents
EP4448499A1 (en) 2021-12-14 2024-10-23 Bracco Imaging SPA Manufacturing of dimeric contrast agent
EP4448133A1 (en) * 2021-12-17 2024-10-23 Rare Earth Technologies, Inc. Chromatographic separation and purification of elemental metals

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213029B (it) 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
GB9115375D0 (en) 1991-07-17 1991-09-04 Salutar Inc Compounds
IT1292128B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici
NO20051911D0 (no) * 2005-04-19 2005-04-19 Amersham Health As Synthesis
EP1999118B1 (en) * 2006-03-14 2012-10-17 Mallinckrodt LLC Metal complexes of tetraazamacrocycle derivatives
EP3177326A4 (en) * 2014-08-07 2018-02-28 Ohio State Innovation Foundation Self-assembling molecules that accumulate in acidic tumor microenvironments
SI3753929T1 (sl) 2015-12-10 2023-01-31 Bracco Imaging Spa Dimerna kontrastna sredstva
RU2743167C2 (ru) 2015-12-10 2021-02-15 Бракко Имэджинг Спа Контрастные агенты
KR101725983B1 (ko) * 2016-02-17 2017-04-11 경북대학교 산학협력단 트리-터셔리-부틸-2,2`,2``-(1,4,7,10-테트라아자사이클로도데칸-1,4,7-트리일)트리아세테이트의 신규한 제조방법
WO2018108780A1 (en) 2016-12-12 2018-06-21 Bracco Imaging Spa Dimeric contrast agents
CN110357828B (zh) * 2019-08-13 2021-03-19 牡丹江医学院 一种核磁共振造影剂及其制备方法和用途

Also Published As

Publication number Publication date
EP4073045B1 (en) 2024-03-20
EP4073045A1 (en) 2022-10-19
CA3157618A1 (en) 2021-06-17
KR20220113936A (ko) 2022-08-17
IL293806A (en) 2022-08-01
AU2020399182A1 (en) 2022-06-09
CN114845998B (zh) 2024-06-25
US20230040042A1 (en) 2023-02-09
ZA202205300B (en) 2023-01-25
WO2021116165A1 (en) 2021-06-17
BR112022009493A2 (pt) 2022-08-16
CN114845998A (zh) 2022-08-02
EP4073045C0 (en) 2024-03-20
JP2023506447A (ja) 2023-02-16
ES2980849T3 (es) 2024-10-03

Similar Documents

Publication Publication Date Title
MX2022007108A (es) Fabricacion de do3a protegido.
SA518400547B1 (ar) مشتقات بيرازولو بيريميدين كمثبط كيناز
PH12018501065A1 (en) Compounds and compositions useful for treating disorders related to ntrk
JOP20180113A1 (ar) مركبات ,تركيبات وطرق
NZ730730A (en) Novel carboxylic acid compounds useful for inhibiting microsomal prostaglandin e2 synthase-1
MX2019012942A (es) Compuestos de imidazo-piperidina fusionada como inhibidores de jak.
MX2021015935A (es) Formas de sal de acido bempedoico y metodos para utilizar el mismo.
WO2016130920A3 (en) Lrrk2 inhibitors and methods of making and using the same
MX2019012815A (es) Proceso para la preparacion de compuestos de 2,3-dihidrotiazolo[3, 2-a]pirimidin-4-io opticamente activo.
TN2020000125A1 (en) Amino-fluoropiperidine derivative as kinase inhibitor
NZ730724A (en) Novel methyl-piperidine compounds useful for inhibiting microsomal prostaglandin e2 synthase-1
WO2016079751A3 (en) A process for preparation of vortioxetine and polymorphs thereof
MX2018006392A (es) Metodo para la preparacion de compuestos que tienen un andamiaje de 16-oxabiciclo[10.3.1]pentadeceno y productos subsecuentes de estos.
TN2020000082A1 (en) Oxy-fluoropiperidine derivative as kinase inhibitor
PH12019502093A1 (en) Novel ester compounds, method for the production thereof and use thereof
GEP20196974B (en) A novel crystalline form of a benzimidazole derivative and a preparation method thereof
WO2016125191A3 (en) Processes for the preparation of vortioxetine hydrobromide
MX2021003862A (es) Formas cristalinas y procesos de besilato de lenvatinib.
MX2023009372A (es) Proceso para la preparacion de compuestos enlazantes de farmaco.
PH12019500370A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
IL289904A (en) A process for preparing biphenylamines
MX2021008323A (es) Preparacion de 5-aril pentanoles.
MX2021004996A (es) Preparacion de 4-metiltetrahidropiranos 2-sustituidos a partir de 4-hidroxi-4-metiltetrahidropiranos 2-sustituidos como materiales de partida.
WO2020012408A3 (en) A process for purification of protected polycyclic carbamoylpyridone derivatives
MX2021002885A (es) Método de manufactura de una forma sólida de un inhibidor de bromodominio de proteínas con bromodominio y dominio extraterminal (bet).